Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
in response to
by
posted on
Feb 17, 2022 12:31PM
Very exciting to see the continued the progress on the science.
I'd like to see some action on the business side now that we know the science is progressing. Where is the funding to pay out the debenture? When will the BoM2 trial be funded and start? Is everything being bet on the success of the Covid trial? If so, when will we see results strong enough to attract investors to fund BoM2?
I sense that Eversana is having a positive impact (just a feeling) but what is needed is a communications strategy and a plan for relentless execution of the strategy in the USA and Europe at least.
It's a good news day for sure.
GLTA
Toinv